QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
BATS:HELX

Franklin Genomic Advancements ETF - HELX Stock Forecast, Price & News

$31.74
+0.36 (+1.15%)
(As of 01/31/2023 04:00 PM ET)
Add
Today's Range
$31.41
▼
$31.74
50-Day Range
$29.53
▼
$32.37
52-Week Range
N/A
Volume
1,219 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Receive HELX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter.

Receive HELX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Franklin Templeton Investments
Fund NameFranklin Genomic Advancements ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:HELX
Inception Date2/25/2020
Fund ManagerMatthew J.Moberg, Joyce Lin
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
Benchmark
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$10.99 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.50%
Other Expenses0.00%
Total Expenses0.50%
Fee Waiver0.00%
Net Expenses0.50%

Administrator, Advisor and Custodian

AdministratorFranklin Templeton Services, LLC
AdvisorFranklin Advisers, Inc.
CustodianState Street Bank and Trust Company
DistributorFranklin Templeton Distributors, Inc.
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerCitadel

Geographic Exposure of HELX

Currency Exposure of HELX

Sector Exposure of HELX

Industry Exposure of HELX














HELX Stock - Frequently Asked Questions

How have HELX shares performed in 2023?

Franklin Genomic Advancements ETF's stock was trading at $30.1272 at the start of the year. Since then, HELX stock has increased by 5.4% and is now trading at $31.74.
View the best growth stocks for 2023 here.

What is Franklin Genomic Advancements ETF's stock symbol?

Franklin Genomic Advancements ETF trades on the BATS under the ticker symbol "HELX."

Who are Franklin Genomic Advancements ETF's major shareholders?

Franklin Genomic Advancements ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Vigilant Capital Management LLC (0.00%).

How do I buy shares of Franklin Genomic Advancements ETF?

Shares of HELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Franklin Genomic Advancements ETF's stock price today?

One share of HELX stock can currently be purchased for approximately $31.74.

This page (BATS:HELX) was last updated on 1/31/2023 by MarketBeat.com Staff